Skip to main content

Table 3 Multivariate analysis of covariates for survival in breast cancer

From: Gene-associated methylation status of ST14 as a predictor of survival and hormone receptor positivity in breast Cancer

Covariates

HR

95% CI

P

TCGA

 GAM status (ref: GAM-Low)

0.16

0.07–0.37

<  0.001

 Age (ref: <= 50)

2.19

1.11–4.35

0.023

 Pathological stage (ref: stage I)

2.79

0.86–6.05

0.09

 Histologic type (ref: IDC)

0.52

1.11–4.35

0.13

PAM50 (ref: normal)

 Luminal A

0.51

0.10–2.56

0.41

 Luminal B

0.74

0.15–3.71

0.71

 Basal

0.28

0.05–1.39

0.11

 Her2

0.47

0.07–3.06

0.42

GSE75067

 GAM status (ref: GAM-Low)

0.39

0.21–0.74

0.003

 Age (ref: <= 50)

2.03

1.25–3.30

0.004

 Histologic type (ref: IDC)

0.61

0.29–1.26

0.18

PAM50 (ref: normal)

 Luminal A

1.99

0.43–9.27

0.37

 Luminal B

4.73

1.07–20.96

0.04

 Basal

4.64

1.05–20.59

0.04

 Her2

7.75

1.77–34.1

0.006

  1. HR hazard ratio, CI confidence interval, GAM gene associated methylation, IDC invasive ductal carcinoma